Paid Clinical Trials in Ann Arbor, MI
As of September 2026, 970 paid clinical trials are recruiting in Ann Arbor, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Ann Arbor offers studies at sites including University of Michigan for conditions such as Heart Failure, Malignant Solid Neoplasm, Obesity, Stroke. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Ann Arbor
Trials by drug in Ann Arbor
Filter results
Newly added in Ann Arbor
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Non-invasive Prediction of EArly Cardiac rEjection
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
Outcomes After Planned Discontinuation of AntiSeizure Medication
Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC
874 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Assessment of CCM in HF With Higher Ejection Fraction
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Top Research Study Locations in Ann Arbor
Researchers run research studies in Ann Arbor, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Michigan | Healthy, Heart Failure, Acute Kidney Injury | 387 |
| University of Michigan Rogel Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | 81 |
| Trinity Health Saint Joseph Mercy Hospital Ann Arbor | Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia | 65 |
| C S Mott Children's Hospital | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Neuroblastoma | 31 |
| University of Michigan Comprehensive Cancer Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Carcinoma | 27 |
| University of Michigan Health System | Chronic Kidney Disease, ADA SCID, Adolescent Congenital Heart Disease | 23 |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | Prostate Cancer, Adult Growth Hormone Deficiency, Alcohol Use Disorder | 22 |
| C.S. Mott Children's Hospital | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Anaplastic Astrocytoma | 17 |
| University of Michigan Hospital | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 13 |
| University of Michigan School of Dentistry | Gum Disease, Healing Wound, Dental Diseases | 9 |
| University of Michigan Health | Aortic Stenosis, Breast Reconstruction, Colorectal Adenoma | 8 |
| University of Michigan Hospitals | Propionic Acidemia, Adenoid Cystic Carcinoma, Chromophobe Renal Cell Carcinoma | 8 |
| University of Michigan Medical Center | Liver Transplant, Cutaneous Melanoma, Stage II, Glomerulosclerosis, Focal Segmental | 7 |
| University of Michigan Kellogg Eye Center | Cone Rod Dystrophy, Juvenile Macular Degeneration, Stargardt Disease | 6 |
| University of Michigan, Michigan Medicine | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 6 |
| CS Mott Children's Hospital | Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Advanced Solid Tumor | 5 |
| Michigan Medicine | Sleep Apnea, Obstructive, Aging, Alzheimer Disease | 5 |
| Trinity Health IHA - Obstetrics and Gynecology West Arbor | Ampulla of Vater Carcinoma, Appendix Carcinoma, Breast Carcinoma | 5 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Multiple Myeloma, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis | 4 |
| Saint Joseph Mercy Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Castration Levels of Testosterone | 4 |
| The University of Michigan | Down Syndrome, Hypertonia, Muscle, Nasal Airway Obstruction | 4 |
| VA Ann Arbor Healthcare System | Cardiovascular Diseases, Castrate-sensitive, Castrate-sensitive Prostate Cancer | 4 |
| University of Michigan Health System - Ann Arbor | Asthma, Plasma Cell Myeloma Refractory, Autoimmune Haemolytic Anaemia | 4 |
| C.S Mott Children's Hospital | Neuroblastoma | 3 |
| Uni Of Michigan Health System | Advanced Malignancies, Diffuse Cutaneous Systemic Sclerosis, Hematologic Malignancy | 3 |
Active & Upcoming Studies in Ann Arbor (2026)
Recruiting trials in Ann Arbor grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (281 active studies)
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · Phase 1 · University of Michigan Rogel Cancer Center
- A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment · Phase 2 · Alliance for Clinical Trials in Oncology
Neurology & pain (75 active studies)
- This Study Evaluates the Use of a Data-driven Lower Limb Exoskeleton Controller for Stroke Rehabilitation. · University of Michigan
- Telerehabilitation for Post-Stroke Hand Function · University of Michigan
Cardiovascular (62 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score · Phase 4 · University of Michigan
Diabetes & metabolic (28 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- A Randomized Controlled Trial of Prepared vs. Unprepared Food · University of Michigan
Mental health & behavior (23 active studies)
- Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression · University of Michigan
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
Pediatric (16 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Eye & vision (10 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · Astellas Pharma Global Development, Inc.
HIV / STI (5 active studies)
- A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH) · University of Michigan
- National Liver Cancer Screening Trial · Phase 4 · University of Texas Southwestern Medical Center
Vaccines (4 active studies)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- KIDney Injury in Times of COVID-19 (KIDCOV) · University of California, San Francisco
Common conditions studied in Ann Arbor
- Heart Failure (10 active studies)
- Malignant Solid Neoplasm (10 active studies)
- Obesity (10 active studies)
- Stroke (10 active studies)
- Acute Myeloid Leukemia (9 active studies)
- Advanced Solid Tumor (9 active studies)
Leading research sponsors in Ann Arbor
- University of Michigan
- University of Michigan Rogel Cancer Center
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Ann Arbor?
There are approximately 970 recruiting clinical trials in Ann Arbor, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ann Arbor pay participants?
Most recruiting trials in Ann Arbor compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ann Arbor?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ann Arbor?
The most common conditions under active study in Ann Arbor include Heart Failure (10), Malignant Solid Neoplasm (10), Obesity (10), Stroke (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ann Arbor?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ann Arbor on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ann Arbor?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ann Arbor?
Recruiting research sites in Ann Arbor include University of Michigan, University of Michigan Rogel Cancer Center, Trinity Health Saint Joseph Mercy Hospital Ann Arbor, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ann Arbor right now?
The largest active categories in Ann Arbor are Cancer & tumors (281), Neurology & pain (75), Cardiovascular (62). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.